Autoimmunity
21
8
8
6
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 85/100
19.0%
4 terminated out of 21 trials
60.0%
-26.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (21)
NIAID Centralized Sequencing Protocol
Targeting GLUT1 to Control Autoimmunity in Type 1 Diabetes
Autoimmunity After Checkpoint Blockade
Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic Dermatitis
Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor Therapy
A Study of Safety and Drug Levels of HIB210 in Healthy Volunteers
Gfree - For Improved Blood Sugar and Reduced Inflammation.
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)
Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management
How Microbes and Metabolism May Predict Skin Cancer Immunotherapy Outcomes
Exploring Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
ASIA-Mesh: a Pilot Study for Diagnostics and Treatment on ASIA Syndrome Caused by Polypropylene Mesh Implantation
Q Fever and Auto-immunity
Autoimmune Gastrointestinal Dysmotility: Symptoms, Pathogenesis and Treatment
Depressed AIRE Gene Expression Causes Immune Cell Dysfunction & Autoimmunity in Down Syndrome
Salt and TH-17 in Healthy Human Subjects
Rheumatologic Adverse Events and Cancer Immunotherapy
Trauma as a Trigger for Autoimmunity
Diabetes Virus Detection Project, Intervention With GAD-alum
Prospective Assessment in Newborns for Diabetes Autoimmunity